glp-1 semaglutide and tirzepatide vs for Weight Loss Semaglutide GLP-1 vs Tirzepatide for

however, it negatively affected the fetal weight, yet it was considered negligible due to liraglutides known effect of suppressing appetite ( As GLP-1 agonists have garnered attention for management of obesity due to their effect on reducing insulin sensitivity, they are now being considered a therapeutic option for the treatment of PCOS (polycystic ovarian syndrome), one of the most common causes of subfertility, diagnosed via Rotterdams criteria: oligomenorrhea, hyperandrogenism and polycystic ovaries ( A comparative study conducted between GLP-1RA + Metformin in contrast to cyproterone acetate/ethinylestradiol + Metformin in overweight PCOS women, conducted over a period of 12 weeks, implied that GLP-1 RA+Metformin was superior in reducing the waist circumferences as well as preserving blood sugar levels by improved HbA1c levels and regulating menstrual cycle

A receptor-independent stimulation of GLP-1 release from GLUTag cells has been reported for oleic acid, which stimulates GLP-1 release by uncoupling oxidative phosphorylation and, hence, indirectly stimulating glycolysis with the resulting activation of the mechanism alluded to above [301]

Ozempic treats type 2 diabetes but may be prescribed off-label for weight loss, if appropriate

The frequency and severity of headaches appear broadly comparable across the GLP-1 receptor agonist class, suggesting a class effect rather than a medication-specific phenomenon

* Correspondence: Gilda Sandri, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

While shows promise, more extensive human clinical trials are needed to fully establish its efficacy